
MACCIA Urges FDA To Avoid Naming Traders Before Legal Guilt Is Established
The story in brief
MACCIA urged FDA not to name traders before legal guilt is established, citing risks of reputational and financial damage. The association emphasized the need for media reports to clarify that samples are only sent for testing. FDA Assistant Director Mangesh Mane responded positively to the memorandum and plans an awareness seminar for traders.